| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |